According to the 2019 update on management of ischemic cerebrovascular diseases released by the Chinese Stroke Association, mechanical thrombectomy (MT) is strongly recommended for eligible patients with AIS and should be performed as the first-line treatment for patients who are ineligible for intravenous recombinant tissue plasminogen activator (IV-tPA) [6]. The gene discussed is PLAT; the disease is Stroke.